Financial Times :press: - Nostr Hypermedia

Novo Nordisk’s obesity drug cuts risk of strokes and heart attacks Shares in Danish drugmaker and US rival Eli Lilly surge to record highs after positive trial of weight-loss drug #press https://www.ft.com/content/b8617703-2608-4d2e-8d39-6d4ab1176ffd?utm_source=press.coop

Goldman hit by senior departures as lower pay and overhaul take toll Some insiders fear it could take years to replace top-tier bankers #press https://www.ft.com/content/fc36dc01-2299-40f8-a00c-3288fac1d37c?utm_source=press.coop

Goldman’s John Rogers steps down as chief of staff Influential bank executive dubbed the ‘board whisperer’ will hand over role to former colleague Russell Horwitz #press https://www.ft.com/content/d0c7b349-51ab-449e-a36e-0525ab9b107f?utm_source=press.coop

The west shouldn’t give up on ‘gentle commerce’ just yet Although it has been strained in recent years, the link between trade and political liberalisation still holds #press https://www.ft.com/content/eb956e76-72e3-40f8-aa7b-66f7da946367?utm_source=press.coop

Rivian boosts EV production target as supply problems ease Company reports narrowing loss as volumes forecast to hit 52,000 this year #press https://www.ft.com/content/b2e558e8-eb98-43ba-afcc-ed9da15e31d2?utm_source=press.coop

Trump admits criminal charges will damage 2024 presidential campaign Former president tells raucous New Hampshire rally he expects fourth indictment as soon as next week #press https://www.ft.com/content/f0bc80d3-2e7b-43cf-a143-79ca0e3c123b?utm_source=press.coop

Eli Lilly/Novo: come for the weight loss, stay for other health benefits Drugs that tackle obesity, diabetes and heart disease are good for profits and the public #press https://www.ft.com/content/b6a91043-9c36-4b6f-b12c-fb3e5838fa7e?utm_source=press.coop

July enters history books as hottest month on record Sea and air temperatures at new highs as global warming breaches 1.5C temporary rise #press https://www.ft.com/content/a9c7b8fa-9dd5-4a32-9994-ef6fb894bcaa?utm_source=press.coop

China’s Country Garden misses bond payments as turmoil grips property sector Real estate crisis continues to drag on world’s second-largest economy #press https://www.ft.com/content/93601476-0c7a-452a-af33-6cc0153acac7?utm_source=press.coop

Meta disbands protein-folding team in shift towards commercial AI Move to terminate scientific project comes as Facebook parent prioritises moneymaking AI products over blue-sky research #press https://www.ft.com/content/919c05d2-b894-4812-aa1a-dd2ab6de794a?utm_source=press.coop

SoftBank/AI: strong Arm narrative exploits market’s machine longing Artificial intelligence has boosted entire tech sector but Masayoshi Son is overstating chip designer’s credentials #press https://www.ft.com/content/5c9f8261-c442-40d5-a647-c67d9d1ce040?utm_source=press.coop

China’s Country Garden misses bond payments as turmoil grips property sector Real estate crisis continues to drag on world’s second-largest economy #press https://www.ft.com/content/93601476-0c7a-452a-af33-6cc0153acac7?utm_source=press.coop

Eli Lilly/Novo: come for the weight loss, stay for other health benefits Drugs that tackle obesity, diabetes and heart disease are good for profits and the public #press https://www.ft.com/content/b6a91043-9c36-4b6f-b12c-fb3e5838fa7e?utm_source=press.coop

Tesla CFO and company veteran Zach Kirkhorn quits One of Elon Musk’s closest lieutenants will be replaced by accounting chief Vaibhav Taneja #press https://www.ft.com/content/cdafab98-39bf-48f5-bf34-8d8b5d1db868?utm_source=press.coop

Google and Universal Music negotiate deal over AI ‘deepfakes’ New technology that can mimic artists’ voices has been seen as growing threat #press https://www.ft.com/content/6f022306-2f83-4da7-8066-51386e8fe63b?utm_source=press.coop

Administrator for Greensill Bank sues insurer Zurich for $250mn Suit in London’s High Court seeking claims over debts tied to a company owned by industrialist Sanjeev Gupta #press https://www.ft.com/content/544f0ed3-cdcf-4a7b-914e-2c30a7da012a?utm_source=press.coop

S&P drops ESG scores from debt ratings amid scrutiny Agency will no longer rank companies’ environmental, social and governance risks from 1 to 5 #press https://www.ft.com/content/9426937e-28d3-4846-8440-c30583524d4c?utm_source=press.coop

Eli Lilly/Novo: come for the weight loss, stay for other health benefits Drugs that tackle obesity, diabetes and heart disease are good for profits and the public #press https://www.ft.com/content/b6a91043-9c36-4b6f-b12c-fb3e5838fa7e?utm_source=press.coop

Novo Nordisk’s obesity drug cuts risk of strokes and heart attacks Shares in Danish drugmaker and US rival Eli Lilly surge to record highs after positive trial of weight-loss drug #press https://www.ft.com/content/b8617703-2608-4d2e-8d39-6d4ab1176ffd?utm_source=press.coop

US bank stocks fall after Moody’s cuts ratings on several midsized lenders Shares in Italian lenders slide after government announces windfall tax plans #press https://www.ft.com/content/db294c43-a7a4-47b5-9b5d-341166702b20?utm_source=press.coop